-
Company Insights
New![]()
Innovation and Patenting activity of JTC Plc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of JTC Plc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – JTC-064 in Neurodegenerative Diseases
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. JTC-064 in Neurodegenerative Diseases Drug Details: JTC-064 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-474121 in Alzheimer’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BI-474121 in Alzheimer's Disease Drug Details:BI-474121 is under development for the treatment of cognitive impairment in...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Small Molecule To Target Psma For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Small Molecule To Target Psma For Metastatic Hormone Refractory Prostate Cancer in Metastatic Castration-Resistant Prostate Cancer...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EI-201 in Head And Neck Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.EI-201 in Head And Neck CancerDrug Details:EI-201 is under development for the treatment of human papilloma...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Resomelagon in Peritonitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Resomelagon in Peritonitis Drug Details: Resomelagon is under development for the treatment of systemic inflammatory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Daratumumab in Primary Systemic Amyloidosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Daratumumab in Primary Systemic Amyloidosis Drug Details: Daratumumab ((HuMax-CD38, JNJ-54767414, Darzalex, Dalinvi, Darzalex Faspro) is an...
-
Product Insights
![]()
JTC Corp – JTC Space @ AMK Industrial Building – North East
Equip yourself with the essential tools needed to make informed and profitable decisions with our JTC Corp - JTC Space @ AMK Industrial Building - North East report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
![]()
JTC – Surrey Hotel and Residential Development – British Columbia
Equip yourself with the essential tools needed to make informed and profitable decisions with our JTC - Surrey Hotel and Residential Development - British Columbia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
JTC Corp – Multi-Storey Recycling Factory – Singapore
Equip yourself with the essential tools needed to make informed and profitable decisions with our JTC Corp - Multi-Storey Recycling Factory - Singapore report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.